Internal governance for review and approval of CPV reports and summaries Internal Governance for Review and Approval of CPV Reports and Summaries Continued Process Verification (CPV) is an essential aspect of quality management for pharmaceutical products, ensuring that manufacturing processes remain in a state of control throughout the product lifecycle. The governance surrounding the review and approval of CPV reports and summaries is crucial for meeting regulatory expectations and maintaining product quality. This article will explore the internal governance frameworks that govern the review and approval of CPV reports, the significance of these processes from a regulatory perspective, and best…

Integration of CPV Summaries into Regulatory Variation and Supplement Filings Integration of CPV Summaries into Regulatory Variation and Supplement Filings Continued Process Verification (CPV) has gained significance within the pharmaceutical industry as a pivotal element in maintaining product quality and ensuring regulatory compliance. As regulations evolve, particularly from key agencies like the FDA, EMA, and MHRA, incorporating CPV data into regulatory submissions, including variation and supplement filings, has become essential. This article aims to provide a comprehensive explainer manual on how CPV summaries can be effectively integrated into these regulatory processes, emphasizing best practices and regulatory expectations. Understanding Continued Process…

Regulatory intelligence on how agencies reference CPV in guidances and Q and As Regulatory Intelligence on How Agencies Reference CPV in Guidances and Q and As Introduction to Continued Process Verification (CPV) Continued Process Verification (CPV) represents a pivotal aspect of modern pharmaceutical manufacturing, critiqued by regulatory authorities for its emphasis on real-time quality assurance throughout the product lifecycle. The FDA, EMA, and MHRA are increasingly relying on CPV as an essential part of the Quality by Design (QbD) approach, designed to offer flexibility and enhance the quality of medicines while reducing variations. CPV requires a continuous monitoring framework, which…

Leveraging CPV for Post Approval Commitments and Ongoing Verification Plans Leveraging CPV for Post Approval Commitments and Ongoing Verification Plans Continued Process Verification (CPV) is an essential component of modern pharmaceutical quality systems, serving as a transformative framework to ensure ongoing compliance and product integrity post-approval. As regulatory expectations evolve, understanding how to effectively leverage CPV for post-approval commitments and ongoing verification plans becomes critical for pharmaceutical professionals. This article provides a comprehensive overview of CPV, its regulatory implications, and best practices for implementation within the context of the FDA, EMA, and MHRA frameworks. Understanding Continued Process Verification Continued Process…

Connecting CPV Reports to Management Review and Site Quality Metrics Connecting CPV Reports to Management Review and Site Quality Metrics Continued Process Verification (CPV) plays a critical role in the lifecycle management of pharmaceutical products. As outlined in the FDA Guidance on Process Validation (2011) and reinforced in the ICH Q8(R2) document, CPV enables organizations to monitor, evaluate, and manage product consistency and quality over time. This article serves to delineate the intricate connections between CPV reporting, management review, and site quality metrics, providing insights into regulatory expectations pertinent to CPV activities within the US, UK, and EU. Understanding Continued…

How to structure CPV narratives to tell a clear risk based story How to Structure CPV Narratives to Tell a Clear Risk-Based Story Continued Process Verification (CPV) is a crucial element in the lifecycle management of pharmaceutical products. It allows for the ongoing monitoring and evaluation of processes to ensure consistent product quality. Understanding how to structure CPV narratives effectively can aid regulatory compliance, enhance communication among stakeholders, and support sound decision-making processes. This article serves as a comprehensive guide for industry professionals on how to create clear and risk-based CPV narratives applicable in various contexts, including CPV reporting for…

Common gaps in CPV reporting identified during inspections and audits Common Gaps in CPV Reporting Identified During Inspections and Audits In the highly regulated pharmaceutical industry, Continued Process Verification (CPV) plays a critical role in ensuring product quality and compliance with regulatory requirements. As organizations strive to enhance their CPV systems and practices, identifying and addressing common gaps can significantly improve both inspection readiness and overall product lifecycle management. This article provides a detailed examination of common deficiencies encountered during CPV reporting as identified through inspections and audits by regulatory authorities such as the US FDA, EMA, and MHRA, while…

Global expectations for CPV use in lifecycle regulatory decision making Global expectations for Continued Process Verification (CPV) use in lifecycle regulatory decision making Continued Process Verification (CPV) has become a cornerstone concept in ensuring quality throughout the lifecycle of pharmaceutical products. As regulatory frameworks continuously evolve, the importance of integrating robust CPV strategies has been recognized not only by the FDA but also by global regulatory authorities including the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA). This article will provide a comprehensive overview of the current expectations for CPV use, with a particular emphasis…

Future of CPV Reporting Digital, Interactive and Directly Sourced from Analytics Future of CPV Reporting Digital, Interactive and Directly Sourced from Analytics The landscape of Continued Process Verification (CPV) reporting is experiencing a transformative shift driven by the increasing integration of digital technologies and analytics. Regulatory expectations from agencies like the US FDA, EMA, and MHRA are evolving to prioritize robust, data-driven insights that support product quality and patient safety. This article aims to provide an in-depth regulatory explainer on the future of CPV reporting, examining its application for Annual Product Reviews (APR) and Product Quality Reviews (PQR), and discussing…

Best practice case examples where CPV supported successful regulatory outcomes Best Practice Case Examples Where CPV Supported Successful Regulatory Outcomes Introduction to Continued Process Verification (CPV) Continued Process Verification (CPV) is a critical component in the pharmaceutical and biopharmaceutical industries aimed at ensuring that processes remain in a state of control throughout the product lifecycle. Defined within the ICH Q8, Q9, and Q10 guidelines, CPV represents a systematic and continuous approach to monitoring and evaluating processes, offering valuable insights that can be leveraged during inspections, submissions, and annual product reviews (APRs). The regulatory expectations from agencies like the FDA, the…